Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schellongowski

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Intensive Care Medicine|September 25, 2025
Acute respiratory distress syndrome in patients with cancer: the YELENNA prospective multinational observational cohort studyPeter Schellongowski, Michael Darmon, Philipp Eller, et al.
Chest|June 23, 2020
Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM StudyAlexandre Demoule, Massimo Antonelli, Peter Schellongowski, et al.
Critical Care (London, England)|March 27, 2026
Incidence and outcomes of influenza-associated pulmonary aspergillosis and the role of antifungal prophylaxis: a structured literature reviewSarah Sedik, Daniel Felber, Peter Schellongowski, et al.
The Lancet. Haematology|April 24, 2021
Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort studyÉlie Azoulay, Pedro Castro, Adel Maamar, et al.
Annals of Intensive Care|June 8, 2026
Dyspnea as a marker of prognosis in immunocompromised patients with acute respiratory failureAlexandre Demoule, Maxens Decavèle, Sangeeta Mehta, et al.
Annals of Intensive Care|October 22, 2020
Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia statusDjamel Mokart, Michael Darmon, Peter Schellongowski, et al.
The Lancet. Respiratory Medicine|November 19, 2022
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational studyRoberto Lorusso, Maria Elena De Piero, Silvia Mariani, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2023
Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO StudyGennaro Martucci, Marco Giani, Matthieu Schmidt, et al.
The Lancet. Respiratory Medicine|October 14, 2022
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational studyGennaro Martucci, Matthieu Schmidt, Cara Agerstrand, et al.
Intensive Care Medicine|February 11, 2022
Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysisMatthias Kochanek, Jan Kochanek, Boris Böll, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Intensive Care Medicine|September 25, 2025
Acute respiratory distress syndrome in patients with cancer: the YELENNA prospective multinational observational cohort studyPeter Schellongowski, Michael Darmon, Philipp Eller, et al.
Chest|June 23, 2020
Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM StudyAlexandre Demoule, Massimo Antonelli, Peter Schellongowski, et al.
Critical Care (London, England)|March 27, 2026
Incidence and outcomes of influenza-associated pulmonary aspergillosis and the role of antifungal prophylaxis: a structured literature reviewSarah Sedik, Daniel Felber, Peter Schellongowski, et al.
The Lancet. Haematology|April 24, 2021
Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort studyÉlie Azoulay, Pedro Castro, Adel Maamar, et al.
Annals of Intensive Care|June 8, 2026
Dyspnea as a marker of prognosis in immunocompromised patients with acute respiratory failureAlexandre Demoule, Maxens Decavèle, Sangeeta Mehta, et al.
Annals of Intensive Care|October 22, 2020
Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia statusDjamel Mokart, Michael Darmon, Peter Schellongowski, et al.
The Lancet. Respiratory Medicine|November 19, 2022
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational studyRoberto Lorusso, Maria Elena De Piero, Silvia Mariani, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2023
Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO StudyGennaro Martucci, Marco Giani, Matthieu Schmidt, et al.
The Lancet. Respiratory Medicine|October 14, 2022
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational studyGennaro Martucci, Matthieu Schmidt, Cara Agerstrand, et al.
Intensive Care Medicine|February 11, 2022
Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysisMatthias Kochanek, Jan Kochanek, Boris Böll, et al.
Pageof 14